Fundraising FoxBiolytx
Oklahoma City, US · 1 known investors
Find your way into Biolytx
Sign up to find every way you can get introduced to Biolytx
- Your email: who you already know at Biolytx, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biolytx team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
Founders & leadership
HA
H. Anne Pereira, PhDChief Scientific Officer, Co-Founder
WA
William A. HagstromBoard Member, Co-Founder
HA
Heloise Anne PereiraProfessor / Inventor
Investors · 1
In the news
Frequently asked questions
- What does Biolytx do?
- Biolytx Pharmaceuticals is developing a novel antibiotic peptide, currently in pre-clinical trials, to treat serious hospital-acquired infections including those resistant to existing antibiotics. It operates in the biotechnology and pharmaceutical drug development sector.
- Who founded Biolytx?
- Biolytx was founded by H. Anne Pereira, PhD, William A. Hagstrom.
- Who are Biolytx's investors?
- Biolytx's investors include Crawley Ventures.
- Where is Biolytx headquartered?
- Biolytx is headquartered in Oklahoma City, US.